| Net Cash Provided by (Used in) Operating Activities |
$-1,902,417 |
USD |
-147.38% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$228,955 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$-34,387 |
USD |
-83.7% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
975,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
47,075,189 |
shares |
184% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$-1,707,849 |
USD |
-116.81% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$2,993,654 |
USD |
-11.46% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$5,331,273 |
USD |
30% |
Q4 2024 |
FY 2024 |
| Depreciation |
$879 |
USD |
-41.2% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$1,695 |
USD |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$311,128,354 |
USD |
89% |
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$496,969 |
USD |
-75.95% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$665,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |